In a report released today, Michael Matson from Needham maintained a Hold rating on Cardiovascular Systems (CSII). The company’s shares opened today at $37.99.
According to TipRanks.com, Matson is a 5-star analyst with an average return of 12.0% and a 65.7% success rate. Matson covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Zimmer Biomet Holdings, and Merit Medical Systems.
Cardiovascular Systems has an analyst consensus of Hold.
See today’s analyst top recommended stocks >>
Based on Cardiovascular Systems’ latest earnings release for the quarter ending December 31, the company reported a quarterly net profit of $489K. In comparison, last year the company had a net profit of $360K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications.
